<DOC>
	<DOCNO>NCT02875171</DOCNO>
	<brief_summary>Anthracycline therapy well-known adverse cardiac effect . Anthracycline-induced cardiotoxicity ( AIC ) associate poor prognosis ; since classical heart failure treatment potentially reverse cardiac dysfunction early stage cardiac toxicity , early detection AIC crucial . Transthoracic echocardiography recommend monitoring leave ventricular function patient receive molecule . In routine practice , leave ventricular systolic function mainly assess left ventricular ejection fraction ( LVEF ) , measure two-dimensional echocardiography imaging . However , LVEF depend operator 's experience sensitive enough detect subclinical myocardial dysfunction . To overcome limitation , two-dimensional speckle-tracking imaging propose . This technique allow study global regional myocardial deformation , especially longitudinal component , appear sensitive one . Several study already emphasize role global longitudinal strain ( GLS ) detect slight alteration systolic function , especially set potentially cardiotoxic drug even low moderate dos anthracyclines . A recent expert consensus paper strongly recommend GLS assessment detection subclinical leave ventricular dysfunction due anthracycline therapy . Although grow evidence GLS predict subsequent alteration LVEF , data exist optimal timing perform echocardiography . The investigator hypothesize early measurement GLS time course anthracycline therapy could predict subsequent left ventricular systolic dysfunction . The aim study , therefore , determine whether assessment GLS 150 mg/m² anthracyclines predict AIC .</brief_summary>
	<brief_title>Assessment Global Longitudinal Strain Prediction Anthracycline Induced Cardiotoxicity</brief_title>
	<detailed_description>Study population : This single-centre , prospective cohort study . The patient evaluate four time point : visit 1 ( V1 ) , initiation anthracycline therapy ; visit 2 ( V2 ) , reach cumulative dose 150 mg/m² ; visit 3 ( V3 ) , end treatment ; visit 4 ( V4 ) , 1 year V1 . Clinical examination visit standard echocardiography perform . The study approve ethic committee ( EudraCT number 2011-002721- 22 ) . Two-dimensional echocardiography : Echocardiography examination perform use Vivid E9 image device ( GE Medical system , Horten , Norway ) . The left ventricular end-diastolic endsystolic volume measure apical two- four-chamber view ; LVEF calculate use Simpson 's rule . GLS compute high frame rate ( &gt; 50 frame per second ) apical view ( four- , two- , three-chamber ) . By trace endocardial border end-systolic frame , myocardial speckle automatically track subsequent frame . Adequate track verify , manually correct necessary . GLS obtain average regional strain . Percentage change GLS absolute reduction GLS calculate baseline V2 . Other classic diastolic systolic parameter record accord current guideline . Digital loop store off-line analysis . For LVEF GLS , digital loop do triplicate ass inter- intraobserver variability . LVEF GLS analyse two reader . The reader blind 's measurement patient visit number . Echocardiographic definition AIC : According recent consensus paper , anthracycline cardiotoxicity define decrease LVEF &gt; 10 percentage point , value &lt; 53 % , V4 . This decrease confirm repeat echocardiography perform week V4 .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>1. patient suffer lymphoma leukemia require anthracycline therapy ; 2. 18 year old ; 3. baseline LVEF &gt; 50 % . 1. moderate severe aortic mitral valve disease ; 2. pregnant breastfeed woman ; 3. atrial fibrillation ; 4. poor image quality define two myocardial segment inadequately visualize ( 17segment model ) ; 5. unstable cardiac condition pericardial effusion acute coronary syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anthracyclines ; Cardiotoxicity ; 2-D Echocardiography</keyword>
</DOC>